What is it about?

Hospitalized patients who harbor multidrug resistant organisms can go undetected in the gastrointestinal tract. Surveillance screening of patients can help identify patients with antimicrobial resistant genes that can cause severe infections.

Featured Image

Why is it important?

We describe the use of a commercial assay that detects 5 carbapenemase genes that have been recognized as severe threats to the public health. Using molecular assays is more sensitive and rapid than traditional culture-based methods. Rapid results provide actionable, objective data to allow for interventions to protect patients.

Read the Original

This page is a summary of: Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay, Journal of Clinical Microbiology, May 2017, ASM Journals,
DOI: 10.1128/jcm.00137-17.
You can read the full text:

Read

Contributors

The following have contributed to this page